August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children’s Hospital Medical Center shows that multiple beams and intervals in delivery during FLASH proton therapy treatment reduced skin-saving effects in preclinical models.
The study was published in the International Journal of Radiation Oncology, Biology, Physics.
FLASH is an experimental mode of delivering radiation therapy for cancer that can be delivered to a patient in less than one second and which can be over 100 times faster than conventional radiation therapy.
Research in the laboratory suggests that FLASH may be safer than standard forms of radiation and, in many cases, causes fewer side effects, including irritation or burning of the skin.
“FLASH proton pencil-beam-scanning has shown a reduction in skin toxicity for preclinical models when delivered in a single, uninterrupted high dose,” says Mathieu Sertorio, PhD, corresponding author on the paper and a member of the basic science research program within the Center. “However, for treatment of patients, multiple beams are required to diminish the exposure of normal tissue to radiation and to make sure the entire area identified for treatment is targeted. The administration of these beams are separated by minutes to allow patient and equipment repositioning.”
In this study, researchers from the center delivered a particular radiation dose of FLASH radiotherapy in either a single or multiple beams in one area of a model and observed skin tissue over the course of 16 weeks at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center. This proton therapy center has the only research-dedicated room in the world.
“The treatment was delivered as one, two or three equal beams with an interruption of two minutes simulating the clinical experience of patients,” explained Sertorio.
Sertorio says that the single beam delivery showed a maximum benefit to skin, but when it was interrupted for two minutes and then readministered in the same area, it reduced the FLASH skin-saving effect. After two interruptions, the skin tissue-sparing effect was further eliminated.
“Our results indicate that the FLASH skin-sparing effect in areas of beam overlap were diminished by multiple beams as opposed to single beams,” he says. “This study suggests the number of beams and the spatial arrangement of those beams are important parameters for FLASH studies. Furthermore, the effect of multibeam delivery is likely different for different organs of interest.”
"This study is important because it informs the clinical translation of FLASH radiotherapy, with respect to beam delivery modalities, treatment planning and radiation prescriptions,” says co-author Anthony Mascia, PhD, of Cincinnati Children’s. “We need to identify where FLASH works and where FLASH doesn't work to move forward."
This research was funded by Varian, a Siemens Healthineers company. Sertorio, as well as co-investigators Mascia and John Perentesis, MD, from Cincinnati Children’s report research grants from Varian.
For more information: www.uc.edu/
Related Content:
VIDEO: First FLASH Proton Therapy Trial Completed in Humans
7 Trends in Radiation Therapy at ASTRO 2021
Radiation Oncology Research Featured at ASTRO 2021
Photo Gallery of Technologies at ASTRO 2021
VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy — Interview with Jeffrey T. Chapman
VIDEO: 4 Radiation Oncology Technologies to Watch — Interview with Anthony Zietman, M.D.
VIDEO: Advances in Radiopharmaceutical Therapy — Interview with Ana Kiess, M.D., Ph.D.
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare — Interview with Walter Curran, Jr. M.D.,
VIDEO: Elekta Harmony Radiotherapy System Walk-around
VIDEO Example of the Varian Noona Bidirection Oncology Patient Interface Software
VIDEO: Examples of Cherenkov Radiation Imaging During Radiation Therapy
July 24, 2024 
